Immunotherapy: Building a bridge to a cure for type 1 diabetes von Bluestone, Jeffrey A, Buckner, Jane H, Herold, Kevan C

Volltext

Quantifying the effect of experimental perturbations at single-cell resolution von Burkhardt, Daniel B., Stanley, Jay S., Tong, Alexander, Perdigoto, Ana Luisa, Gigante, Scott A., Herold, Kevan C., Wolf, Guy, Giraldez, Antonio J., van Dijk, David, Krishnaswamy, Smita

Volltext

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association von Insel, Richard A, Dunne, Jessica L, Atkinson, Mark A, Chiang, Jane L, Dabelea, Dana, Gottlieb, Peter A, Greenbaum, Carla J, Herold, Kevan C, Krischer, Jeffrey P, Lernmark, Åke, Ratner, Robert E, Rewers, Marian J, Schatz, Desmond A, Skyler, Jay S, Sosenko, Jay M, Ziegler, Anette-G

Volltext

Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes von Wright, Jordan J, Salem, Joe-Elie, Johnson, Douglas B, Lebrun-Vignes, Bénédicte, Stamatouli, Angeliki, Thomas, James W, Herold, Kevan C, Moslehi, Javid, Powers, Alvin C

Volltext

Natural mucosal barriers and COVID-19 in children von Pierce, Carl A, Sy, Sharlene, Galen, Benjamin, Goldstein, Doctor Y, Orner, Erika, Keller, Marla J, Herold, Kevan C, Herold, Betsy C

Volltext

Control of TH17 cells occurs in the small intestine von Esplugues, Enric, Huber, Samuel, Gagliani, Nicola, Hauser, Anja E., Town, Terrence, Wan, Yisong Y., O’Connor, William, Rongvaux, Anthony, Van Rooijen, Nico, Haberman, Ann M., Iwakura, Yoichiro, Kuchroo, Vijay K., Kolls, Jay K., Bluestone, Jeffrey A., Herold, Kevan C., Flavell, Richard A.

Volltext

Detection of β cell death in diabetes using differentially methylated circulating DNA von Akirav, Eitan M, Lebastchi, Jasmin, Galvan, Eva M, Henegariu, Octavian, Akirav, Michael, Ablamunits, Vitaly, Lizardi, Paul M, Herold, Kevan C

Volltext

Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome von Perdigoto, Ana Luisa, Quandt, Zoe, Anderson, Mark, Herold, Kevan C

Volltext

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial von Sherry, Nicole, Dr, Hagopian, William, MD, Ludvigsson, Johnny, Prof, Jain, Sunil M, MD, Wahlen, Jack, MD, Ferry, Robert J, Prof, Bode, Bruce, MD, Aronoff, Stephen, MD, Holland, Christopher, MS, Carlin, David, PhD, King, Karen L, MS, Wilder, Ronald L, MD, Pillemer, Stanley, MD, Bonvini, Ezio, MD, Johnson, Syd, PhD, Stein, Kathryn E, PhD, Koenig, Scott, MD, Herold, Kevan C, Prof, Daifotis, Anastasia G, MD

Volltext

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function von Jessel, Shlomit, Weiss, Sarah A, Austin, Matthew, Mahajan, Amit, Etts, Katrina, Zhang, Lin, Aizenbud, Lilach, Perdigoto, Ana Luisa, Hurwitz, Michael, Sznol, Mario, Herold, Kevan C, Kluger, Harriet M

Volltext

HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal von Pierce, Carl A, Loh, Lip Nam, Steach, Holly R, Cheshenko, Natalia, Preston-Hurlburt, Paula, Zhang, Fengrui, Stransky, Stephanie, Kravets, Leah, Sidoli, Simone, Philbrick, William, Nassar, Michel, Krishnaswamy, Smita, Herold, Kevan C, Herold, Betsy C

Volltext

Citrullination of glucokinase is linked to autoimmune diabetes von Yang, Mei-Ling, Horstman, Sheryl, Gee, Renelle, Guyer, Perrin, Lam, TuKiet T., Kanyo, Jean, Perdigoto, Ana L., Speake, Cate, Greenbaum, Carla J., Callebaut, Aïsha, Overbergh, Lut, Kibbey, Richard G., Herold, Kevan C., James, Eddie A., Mamula, Mark J.

Volltext

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling von Reed, James C, Preston-Hurlburt, Paula, Philbrick, William, Betancur, Gabriel, Korah, Maria, Lucas, Carrie, Herold, Kevan C

Volltext

Inducing and Administering Tregs to Treat Human Disease von Perdigoto, Ana Luisa, Chatenoud, Lucienne, Bluestone, Jeffrey A, Herold, Kevan C

Volltext

Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β Cells von Tornovsky-Babeay, Sharona, Dadon, Daniela, Ziv, Oren, Tzipilevich, Elhanan, Kadosh, Tehila, Schyr-Ben Haroush, Rachel, Hija, Ayat, Stolovich-Rain, Miri, Furth-Lavi, Judith, Granot, Zvi, Porat, Shay, Philipson, Louis H., Herold, Kevan C., Bhatti, Tricia R., Stanley, Charles, Ashcroft, Frances M., In’t Veld, Peter, Saada, Ann, Magnuson, Mark A., Glaser, Benjamin, Dor, Yuval

Volltext

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial von Wherrett, Diane K, MD, Bundy, Brian, PhD, Becker, Dorothy J, Prof, DiMeglio, Linda A, MD, Gitelman, Stephen E, Prof, Goland, Robin, Prof, Gottlieb, Peter A, Prof, Greenbaum, Carla J, MD, Herold, Kevan C, Prof, Marks, Jennifer B, Prof, Monzavi, Roshanak, MD, Moran, Antoinette, Prof, Orban, Tihamer, MD, Palmer, Jerry P, MD, Raskin, Philip, Prof, Rodriguez, Henry, Prof, Schatz, Desmond, Prof, Wilson, Darrell M, Prof, Krischer, Jeffrey P, Prof, Skyler, Jay S, Dr, Prof

Volltext

Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes von Rui, Jinxiu, Deng, Songyan, Perdigoto, Ana Luisa, Ponath, Gerald, Kursawe, Romy, Lawlor, Nathan, Sumida, Tomokazu, Levine-Ritterman, Maya, Stitzel, Michael L., Pitt, David, Lu, Jun, Herold, Kevan C.

Volltext

Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies von Sosenko, Jay M, Cuthbertson, David, Sims, Emily K, Ismail, Heba M, Nathan, Brandon M, Jacobsen, Laura M, Atkinson, Mark A, Evans-Molina, Carmella, Herold, Kevan C, Skyler, Jay S, Redondo, Maria J

Volltext

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Di... von HEROLD, Kevan C, GITELMAN, Stephen E, MASHARANI, Umesh, HAGOPIAN, William, BISIKIRSKA, Brygida, DONALDSON, David, ROTHER, Kristina, DIAMOND, Beverly, HARLAN, David M, BLUESTONE, Jeffrey A

Volltext

Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID‐19 patients: Comparison with influenza and pre‐pandemic data von Dell'Aquila, Kevin, Lee, Jeylin, Wang, Stephen H., Alamuri, Tharun T., Jennings, Rebecca, Tang, Helen, Mahesh, Sandhya, Leong, Taylor Jan, Fleysher, Roman, Henninger, Erin M., Veeraraghavan, Sudhakar, Mirhaji, Parsa, Hou, Wei, Herold, Kevan C., Duong, Tim Q.

Volltext